Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma

Tumor mutation burden (TMB) is a useful biomarker to predict prognosis and the efficacy of immune checkpoint inhibitors (ICIs). In this study, we aimed to explore the prognostic value of TMB and the potential association between TMB and immune infiltration in lower-grade gliomas (LGGs). Somatic muta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Yin, Wen, Jiang, Xingjun, Tan, Jun, Xin, Zhaoqi, Zhou, Quanwei, Zhan, Chaohong, Fu, Xianyong, Wu, Zhaoping, Guo, Youwei, Jiang, Zhipeng, Ren, Caiping, Tang, Guihua
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7468526/
https://ncbi.nlm.nih.gov/pubmed/32974146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01409
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados